早期前立腺癌に対するヨウ素125密封小線源療法 [in Japanese] soki zenritsusengan ni taisuru yoso 125 mippu shosengen ryoho [in Japanese]
Access this Article
Search this Article
講座Prostate cancer is the most common noncutaneous malignancy of men and the second greatest cause of male cancer death in the USA. With the widespread use of prostate-specific antigen (PSA) screening over the past decade, more men are being diagnosed with early-stage, localised prostate cancer. Several effective treatment options are available for patients with carly prostate cancer today. Prostate brachythcrapy has especiany become an accepted treatment option for early prostate cancer in the USA . The use of transrectal ultrasound ablows the accurate implantation of radioactive seeds into the prostate . The results of brachytherapy are comparable with those of both radical prostatectomy and external beam radiotherapy. Additionally, prostate brachytherapy has been reported to have lower morbidity than radical prostatectomy or external beam radio therapy. In Japan,1-125 prostate brachytherapy was started in September 2003 and has rapidly spread throughout the country. It will deeelop more and more.
慶應醫學 84(1), 1-8, 2007-03-25